GlassScriptPhysician profile
Stuart Thomas Cowley
NPI 1811429756
$19,394.38
in general payments reported to CMS, 2019-2025
22 companies · $6,134 in 2025
The $6,134 reported for 2025 was more than what 94% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,026 · 2022: $5,996 · 2023: $3,527 · 2024: $1,711 · 2025: $6,134.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,051 · Travel and Lodging: $4,322.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,050.90 |
| Travel and Lodging | $4,321.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $9,677.07 | 2021-2025 | Proclaim, Eterna |
| Boston Scientific Corporation | $3,934.50 | 2022-2025 | General - Pain Management, Wavewriter Alpha Prime 16, Clinical Trial Product |
| Medtronic, INC. | $1,606.79 | 2021-2025 | Intellis Adaptivestim, Synchromedii |
| Nevro Corp. | $1,020.22 | 2021-2024 | Senza |
| Globus Medical, INC. | $875.42 | 2025 | Vyrsa V1, Senza |
| Si-Bone, INC. | $700.78 | 2022-2025 | |
| Spr Therapeutics, INC | $483.60 | 2022-2025 | Sprint Pns System |
| Collegium Pharmaceutical, INC. | $433.28 | 2022-2024 | Belbuca, Xtampza |
| Mml US, INC. | $133.13 | 2025 | Reactiv8 |
| Tersera Therapeutics LLC | $124.45 | 2025 | Prialt |
| Depuy Synthes Sales INC. | $86.93 | 2025 | Synflate, Trialtis, Confidence Spinal Cement System |
| Ultragenyx Pharmaceutical INC. | $63.26 | 2022-2023 | |
| Painteq LLC | $58.00 | 2022 | |
| Amgen INC. | $38.52 | 2024-2025 | Evenity, Prolia, Prolia |
| Biohaven Pharmaceutical Holding Company LTD. | $29.02 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $23.01 | 2022 | |
| Vertos Medical, INC. | $22.26 | 2021 | |
| Scilex Pharmaceuticals INC. | $17.27 | 2023 | Ztlido |
| Abbvie INC. | $17.17 | 2024 | |
| Ferring Pharmaceuticals INC. | $17.04 | 2023 | Euflexxa |
| Spinal Simplicity, LLC | $17.01 | 2023 | Ha Minuteman G3-R |
| Ibsa Pharma INC. | $15.65 | 2023 | Tirosint, Licart |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Cowley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.